Be The Match BioTherapies’ Post

Be the Match Biotherapies is now NMDP BioTherapies. New name, same mission: saving lives through cellular therapy. #celltherapy #celltherapymanufacturing #cellandgenetherapy #stemcelltransplant #cartcells #atmps #regenerativemedicine

Know more about Total Body Irradiation (TBI), an advanced therapy that uses comprehensive radiation to prepare the body for stem cell transplants. Learn how this innovative approach enhances treatment success for cancer and blood disorder patients. #TBI #CancerCare #StemCellTransplant #RadiationTherapy #CancerTreatment #StarHospitals #StarHospitalsBanjaraHills #StarHospitalsNanakramguda

Are you struggling with an autoimmune disease? In this video, we delve into the advanced potential of stem cell therapy in Mexico. Explore how stem cell therapy can repair and regenerate damaged tissues, offering new hope for conditions like lupus, rheumatoid arthritis, and multiple sclerosis. Join us on a journey toward better health and a stronger immune system. For detailed information, watch the full video: https://lnkd.in/gzg_Qyrw #StemCell #StemCellTherapy #AutoImmuneDisease #SkinDisease #Repair #StemCellTreatment

In stem cell therapy, only healthy cells are used to ensure effectiveness and safety. Dr. Rafael Gonzalez, with HAYLIE POMROY GROUP, INC , explains that certain cells, like natural killer cells, are selected because of their role in the immune system. These are taken from the person's blood, purified, and activated to work better. This is important as with age, these cells become less functional in fighting harmful entities, such as viruses and mutated cells. Get more insights in this week’s podcast – Regenerative Medicine for Chronic Illness. https://brnw.ch/21wKqMV #stemcells #stemcelltherapy #regenerativemedicine #longCOVID #MECFS #chronicfatigue #chronicillness #celltherapy #autoimmune #immunesystem #biomedicalengineering

Such an impactful and inspiring story.

A patient has become the first to be cured using India's CAR-T cell therapy, India's Central Drugs Standard Control Organisation (CDSCO) has approved the commercial use of India's first indigenous CAR-T cell therapy. NexCAR19. This treatment genetically reprograms a patient's immune system to fight cancer, with Dr. VK Gupta receiving it for just Rs 42 lakh, which would have cost him Rs 4 crore abroad. NexCAR19 is developed by ImmunoACT and is designed to treat B-cell cancers like leukaemia and lymphoma. The therapy is now available in over 30 hospitals in over 10 cities in India, and patients aged above 15 suffering from B-cell cancers are eligible for treatment. Despite new treatments emerging, CAR-T cell therapy remains expensive and inaccessible in India. NexCAR19 developed by Dr. Alka Dwivedi and her colleagues in 2015, is available at a reasonable cost and meets the needs of patients in India's healthcare system. #Cancer #MedicalInnovations ImmunoACT

Ready to Break Free from Autoimmune Disease? Autoimmune conditions can take over your life, but there’s hope. Stem Cell Therapy may help your body heal and regain strength by addressing the root cause. It’s time to explore a path to reclaim your health and freedom. ✨ Discover how stem cell therapy can help improve your immune system. 📞 Talk with one of our experts +1 877-741-8147, dial directly from our profile call option #AutoimmuneDisease #StemCellTherapy #AutoimmuneSupport #lifealteringstemcells #ChronicIllnessHope #StemCellResearch

Relapse is a problem in #MCL, which clonoSEQ® can help by detecting potential relapse early. Learn from Dr. Fenske as he covers the ECOG-ACRIN 4151 study, which uses clonoSEQ® for MRD assessment in MCL patients: https://clonoseq.co/r2i FDA-cleared to measure MRD in MM, CLL, & ALL; CLIA-validated in other lymphoid cancers. Info on sample types & test limitations: https://rb.gy/8tju9y

Phase 1 data of NKGen's SNK01 NK cell therapy, a cyropreserved, autologous enhanced natural killer cell therapy, delivered in the highest dose to date, showed SNK01 demonstrated preliminary clinical benefit without any drug-related adverse events. Learn about the advancement of SNK01 into Phase 2 clinical development in Alzheimer's disease: https://bit.ly/3RgkVj1 #NKCellTherapy #AlzheimersDisease

How can we design more effective T cell therapies? 🤔 Join us for an insightful discussion with Eric de Sousa, Ph.D. candidate and bioinformatician in the Markus Maeurer Lab at the Champalimaud Foundation, for a webinar on June 5th with iRepertoire, Inc.. Eric will present recent data showing differences in TCR repertoires of TILs and their functional phenotypes from various tumor zones. He will also discuss how the TME may impart a particular epigenetic imprint on TILs, information that can be leveraged to develop better cell therapies. Sign up for the webinar today: https://hubs.li/Q02xZXBn0 #TILs #Tcells #TumorMicroenvironment #EpthelialCancer #TcellReceptor #CellTherapy #TCRSequencing #TumorCells #CancerResearch